Tchetgen M B, Sanda M G, Montie J E, Faerber G J
Department of Surgery, University of Michigan Medical Center, Ann Arbor, USA.
J Urol. 2000 Jan;163(1):212-4.
We determine the clinical efficacy of endoscopically injected collagen for the treatment of new onset urinary incontinence in women following cystectomy and orthotopic neobladder.
Three women 58 to 74 years old underwent transurethral collagen injection for stress urinary incontinence following cystectomy and orthotopic neobladder. Before cystectomy 2 women denied having any stress urinary incontinence while 1 complained of mild incontinence. Onset of incontinence following cystectomy and neobladder formation ranged from 8 months to 3 years, and average pad use ranged from 3 to 5 per 24-hour period. All patients underwent video urodynamic evaluation before collagen injection. Neobladder capacity was 180 to 400 cc and Valsalva leak point pressures ranged from 30 to 60 cm. water.
A total of 6 injections were given, including 3 injections in 1 patient, 2 in 1 and 1 in 1. All 3 women had significant improvement or became dry with initial injection but required repeat injections to maintain improved continence status. At 7 to 8 months after the last injection 1 woman was dry, 1 used 1 or no pad daily and 1 reported no durable change in stress urinary incontinence.
Collagen injection appears to be a successful, minimally invasive treatment for new onset stress urinary incontinence following cystectomy and orthotopic neobladder in women.
我们确定经内镜注射胶原蛋白治疗女性膀胱切除术后原位新膀胱所致新发尿失禁的临床疗效。
3名年龄在58至74岁的女性在膀胱切除术后原位新膀胱形成后,因压力性尿失禁接受了经尿道胶原蛋白注射。膀胱切除术前,2名女性否认有任何压力性尿失禁,而1名女性主诉有轻度尿失禁。膀胱切除术后新膀胱形成后尿失禁的发病时间为8个月至3年,每24小时平均使用尿垫数为3至5片。所有患者在胶原蛋白注射前均接受了影像尿动力学评估。新膀胱容量为180至400立方厘米,瓦尔萨尔瓦漏尿点压力范围为30至60厘米水柱。
共进行了6次注射,其中1例患者注射3次,1例注射2次,1例注射1次。所有3名女性在首次注射后均有显著改善或不再漏尿,但需要重复注射以维持改善后的控尿状态。在最后一次注射后7至8个月时,1名女性不再漏尿,1名女性每天使用1片或不用尿垫,1名女性报告压力性尿失禁无持久变化。
胶原蛋白注射似乎是治疗女性膀胱切除术后原位新膀胱所致新发压力性尿失禁的一种成功的微创治疗方法。